New Study Reveals How Vascular Cells Drive Coronary Artery Disease Risk
New Study Reveals How Vascular Cells Drive Coronary Artery Disease Risk
New Study Reveals How Vascular Cells Drive Coronary Artery Disease Risk
A new study has uncovered how changes in vascular smooth muscle cells (VSMCs) influence the risk of coronary artery disease. Published in Nature Communications, the research identifies specific molecular pathways that link cell behaviour to heart disease progression. These findings challenge long-held assumptions about how vascular lesions develop.
The team used computational models to track VSMC state transitions, mapping how these cells shift between different forms in response to environmental signals. Traditionally seen as passive structural elements, VSMCs are now understood to adopt varied roles—some promoting inflammation and plaque instability. Researchers found that abnormal transitions toward pro-inflammatory states worsen vascular inflammation, increasing the likelihood of heart attacks and other cardiac events.
Single-cell analysis revealed 14 distinct VSMC trajectories, seven of which were tied to known genetic risk factors for coronary disease. Key variants—such as rs9349379 (GATA4), rs12936587 (SMG6/9), and rs17114036 (PHB)—were shown to regulate critical points in these cell state changes. Transcription factors like KLF4 and myocardin acted as master regulators, balancing contractile and synthetic states, while epigenetic modifications further influenced these shifts.
To confirm their findings, the team tested the results in live models of coronary artery disease. The experiments validated the existence of the identified VSMC states and linked them directly to the severity of arterial lesions.
The study connects dynamic VSMC behaviour to coronary disease risk, showing how genetic and molecular factors drive cell state transitions. By integrating cellular and genetic data, the research offers a clearer picture of how vascular lesions form. These insights may help refine future approaches to diagnosing and treating coronary artery disease.